pdufa date for tirzepatide RTTNews | BIG WEEK AHEAD IN BIOTECH We're tracking 1 and 1 event — including: → CELC: FDA decision July 17, 2026 → AAIC 2026: Wegovy (semaglutide) FDA Approval History

Zhang Y, Huang Z, Cheng J, Pan H, Lin T, Shen X, et al

FDA recommended that Jixianglong recall the batches, leading the company to pull the API from the U.S

This medication is typically prescribed to individuals with a body mass index (BMI) of 30 or higher

Good option for those in the Kepong area who prefer an in-clinic experience

Understanding GLP-1RAs and Cardiovascular Health GLP-1RAs mimic native glucagon-like peptide-1, a hormone secreted by intestinal L cells in response to food, which stimulates insulin release and regulates glucose

Conflicting claims and psychological impacts Medical, recreational, and mainstream medications of any kind typically face conflicting views